Journal of Leukocyte Biology Myeloid cells, immune suppression, tumor immunology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2005

Published online before print November 21, 2005
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.1104642v1
78/6/1386    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiménez-Periañez, A.
Right arrow Articles by Portolés, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiménez-Periañez, A.
Right arrow Articles by Portolés, P.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.1104642


Received for publication November 3, 2004.
Revised July 26, 2005.
Accepted for publication August 29, 2005.


Article

Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts

Arturo Jiménez-Periañez *, Gloria Ojeda *, Gabriel Criado *{dagger}, Alejandra Sánchez {ddagger}, Eliana Pini *, Joaquín Madrenas {dagger}, Jose Maria Rojo {ddagger}, and Pilar Portolés *@

*Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; {dagger}Robarts Research Institute and Departments of Microbiology and Immunology and Medicine, The University of Western Ontario, London, Canada; and {ddagger}Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain

@ To whom correspondence should be addressed. E-mail: pportols{at}isciii.es.


   Abstract

Crry/p65 is a type I glycoprotein, which protects mouse T cells from complement attack. We have previously shown that complement receptor I-related protein Crry/p65 (Crry) ligation has a costimulatory effect on mouse CD4+ T cell activation. Here, we have examined the mechanisms responsible for Crry costimulation, addressing the question of whether Crry potentiates signal transduction starting at the T cell receptor (TCR)/CD3 complex or promotes distinct costimulatory signals. We show that Crry increases early TCR-dependent activation signals, including p56lck-, {zeta}-associated protein-70 (ZAP-70), Vav-1, Akt, and extracellular signal-regulated kinase (ERK) phosphorylation but also costimulation-dependent mitogen-activated protein kinases (MAPK), such as the stress-activated c-Jun N-terminal kinase (JNK). It is intriguing that Crry costimulus enhanced p38 MAPK activation in T helper cell type 1 (Th1) but not in Th2 cells. A fraction of Crry is found consistently in the detergent-insoluble membrane fraction of Th1 or Th2 cells or CD4+ lymphoblasts. Crry costimulation induced clustering of lipid rafts, increasing their content in Crry, CD3{varepsilon}, and p59-60 forms of p56lck, and caused actin polymerization close to the site of activation in Th2 cells. Such events were inhibited by wortmannin, suggesting a role for phosphatidylinositol-3 kinase in these effects. The Crry cytoplasmic domain was required for JNK activation and interleukin-4 secretion but not for the presence of Crry in rafts or activation of p56lck, ZAP-70, Akt, Vav-1, or ERK. This suggests that Crry costimulation involves two different but not mutually exclusive signal transduction modules. The dual function of Crry as a complement regulatory protein and as a T cell costimulator illustrates the importance of complement regulatory proteins as links between innate and adaptive immunity.

Key Words: costimulation • cell surface molecule • signal transduction




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. Bello, M. J. Feito, G. Ojeda, P. Portoles, and J. M. Rojo
Loss of N-terminal Charged Residues of Mouse CD3{epsilon} Chains Generates Isoforms Modulating Antigen T Cell Receptor-mediated Signals and T Cell Receptor-CD3 Interactions
J. Biol. Chem., August 3, 2007; 282(31): 22324 - 22334.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the Society for Leukocyte Biology.